Given that OPN is an effective therapeutic target for metastatic HCC, clarification of the signaling pathway of BRMS1-OPN regulation in the future would provide us a new and effective therapeutic approach for HCC. The gene discussed is BRMS1; the disease is hepatocellular carcinoma.